Global Heparin Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Heparin Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global Heparin Sodium market size was valued at US$ 3020 million in 2023 and is forecast to a readjusted size of USD 4409 million by 2030 with a CAGR of 6.0% during review period.

Global Heparin Sodium key players include Shenzhen Hepalink, Bioiberica, Nanjing King-friend, Dongcheng Biochemicals and Changzhou Qianhong Bio-pharma. Global top five manufacturers hold a share about 54%. Europe is the largest market, with a share about 55%, followed by China and North America, with share 22% and 13%, separately. In term of application, the largest application is Low Molecular Weight Heparin Preparations, with a share of 93%.

This report is a detailed and comprehensive analysis for global Heparin Sodium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Heparin Sodium market size and forecasts, in consumption value ($ Million), sales quantity (Million Units), and average selling prices (USD/Million Units), 2019-2030

Global Heparin Sodium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Million Units), and average selling prices (USD/Million Units), 2019-2030

Global Heparin Sodium market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Million Units), and average selling prices (USD/Million Units), 2019-2030

Global Heparin Sodium market shares of main players, shipments in revenue ($ Million), sales quantity (Million Units), and ASP (USD/Million Units), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Heparin Sodium

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Heparin Sodium market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shenzhen Hepalink, Nanjing King-friend, Bioiberica, Dongcheng Biochemicals, Changzhou Qianhong Bio-pharma, Pfizer, Changshan Biochemical, Aspen Oss, Opocrin, Qingdao Jiulong Biopharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Heparin Sodium market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Type A
Type B

Market segment by Application
Standard Heparin Preparation
Low Molecular Weight Heparin Preparations

Major players covered
Shenzhen Hepalink
Nanjing King-friend
Bioiberica
Dongcheng Biochemicals
Changzhou Qianhong Bio-pharma
Pfizer
Changshan Biochemical
Aspen Oss
Opocrin
Qingdao Jiulong Biopharmaceutical
Yino Pharma Limited
Dongying Tiandong Pharmaceutical
Xinbai Pharmaceuticals
Laboratorios Farmaceuticos ROVI
Sichuan Deebio

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Heparin Sodium product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Heparin Sodium, with price, sales quantity, revenue, and global market share of Heparin Sodium from 2019 to 2024.

Chapter 3, the Heparin Sodium competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Heparin Sodium breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Heparin Sodium market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Heparin Sodium.

Chapter 14 and 15, to describe Heparin Sodium sales channel, distributors, customers, research findings and conclusion.